ECO 2026 12 - 15 May 2026

Improved Quality of Life With CagriSema in People with Overweight or Obesity and Poor Physical Function at Baseline: A Post Hoc Analysis of the REDEFINE 1 Trial

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Obesity
Congress poster
Amylin
CagriSema
PHASE 3 (RCT)